Home › Companies › GoodRx Holdings, Inc. › 2024-2025

GoodRx Holdings, Inc. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and GoodRx Holdings, Inc.’s Form 8-K, filed June 4, 2025 (Item 5.07 on EDGAR). Page generated October 14, 2026.

  • 5Ballot items
  • 140Asset managers
  • 577Fund votes
  • June 3, 2025Meeting date

Results at a glance

Meeting of June 3, 2025: 5 items on GoodRx Holdings, Inc.’s Form 8-K, filed June 4, 2025: 5 without a stated outcome.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore GoodRx Holdings, Inc. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by GoodRx Holdings, Inc.

These tallies are GoodRx Holdings, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 4, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

GoodRx Holdings, Inc. — official shareholder meeting results, meeting held June 3, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Christopher Adams 2,601,325,292---- 17,792,25939,105,549 99.3%Not verified—
Elect Director: Trevor Bezdek 2,605,031,761---- 14,085,79039,105,549 99.4%Not verified—
Elect Director: Scott Wagner 2,603,777,388---- 15,340,16339,105,549 99.4%Not verified—
2. Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 2,656,638,262535,5591,049,279 --0 99.9%Not verified—
3. Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers 2,617,157,3771,705,462254,712 --39,105,549 99.9%Not verified—

Source: GoodRx Holdings, Inc., Form 8-K, filed with the SEC on June 4, 2025 — read the filing on EDGAR.

How asset managers voted at the GoodRx Holdings, Inc. 2024-2025 meeting

Each item below shows how the 140 asset managers that disclosed a GoodRx Holdings, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Christopher Adams

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%
FOR: 2,601,325,292WITHHELD: 17,792,259
Details: description as filed, official tally, votes by 32 asset managers

Description as filed by funds: Election of Directors: Christopher Adams

GoodRx Holdings, Inc.’s own tally for this item (“Elect Director: Christopher Adams”): 2,601,325,292 for, 17,792,259 withheld, per its Form 8-K filed June 4, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.3% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 32 asset managers below reported 11,202,501 for, 4,035,067 withheld, 24,479 abstained.

FORWITHHOLD
FOR: 11,202,501ABSTAIN: 24,479WITHHOLD: 4,035,067
Largest asset managers voting on “Election of Directors: Christopher Adams” at GoodRx Holdings, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,651,2540 00For
Columbia Threadneedle00 01,328,823Withhold
Dimensional00 01,188,530Withhold
Fidelity971,7980 00For
State Street2650 0859,745Withhold
Legg Mason734,7000 00For
Charles Schwab521,4560 00For
T. Rowe Price00 0187,094Withhold
Guardian Variable Products Trust176,7000 00For
WisdomTree00 0163,043Withhold
BlackRock103,5520 00For
Thrivent00 086,658Withhold
NORTHERN LIGHTS FUND TRUST III00 075,772Withhold
Northern Trust00 052,579Withhold
Russell Investments25,6220 00For
Jackson National00 21,2680Abstain
Victory Capital00 017,562Withhold
American Century00 015,585Withhold
Prudential/PGIM00 012,470Withhold
Blackstone Alternative Investment Funds00 012,200Withhold
Goldman Sachs00 011,738Withhold
Lincoln Financial00 08,959Withhold
New Age Alpha Funds Trust00 06,846Withhold
RBB FUND, INC.6,3790 00For
NORTHERN LIGHTS FUND TRUST II6,3740 00For

Showing the 25 largest of 32 asset managers. See all 32 in the interactive database.

2. Elect Director: Scott Wagner

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 2,603,777,388WITHHELD: 15,340,163
Details: description as filed, official tally, votes by 32 asset managers

Description as filed by funds: Election of Directors: Scott Wagner

GoodRx Holdings, Inc.’s own tally for this item (“Elect Director: Scott Wagner”): 2,603,777,388 for, 15,340,163 withheld, per its Form 8-K filed June 4, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.4% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 32 asset managers below reported 11,377,128 for, 3,860,440 withheld, 24,479 abstained.

FORWITHHOLD
FOR: 11,377,128ABSTAIN: 24,479WITHHOLD: 3,860,440
Largest asset managers voting on “Election of Directors: Scott Wagner” at GoodRx Holdings, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,651,2540 00For
Columbia Threadneedle00 01,328,823Withhold
Dimensional00 01,188,530Withhold
Fidelity971,7980 00For
State Street1110 0859,899Withhold
Legg Mason734,7000 00For
Charles Schwab521,4560 00For
T. Rowe Price00 0187,094Withhold
Guardian Variable Products Trust176,7000 00For
WisdomTree163,0430 00For
BlackRock103,5520 00For
Thrivent00 086,658Withhold
NORTHERN LIGHTS FUND TRUST III00 075,772Withhold
Northern Trust00 052,579Withhold
Russell Investments25,6220 00For
Jackson National00 21,2680Abstain
Victory Capital00 017,562Withhold
American Century00 015,585Withhold
Prudential/PGIM00 012,470Withhold
Blackstone Alternative Investment Funds00 012,200Withhold
Goldman Sachs11,7380 00For
Lincoln Financial00 08,959Withhold
New Age Alpha Funds Trust00 06,846Withhold
RBB FUND, INC.6,3790 00For
NORTHERN LIGHTS FUND TRUST II6,3740 00For

Showing the 25 largest of 32 asset managers. See all 32 in the interactive database.

3. Elect Director: Trevor Bezdek

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 2,605,031,761WITHHELD: 14,085,790
Details: description as filed, official tally, votes by 32 asset managers

Description as filed by funds: Election of Directors: Trevor Bezdek

GoodRx Holdings, Inc.’s own tally for this item (“Elect Director: Trevor Bezdek”): 2,605,031,761 for, 14,085,790 withheld, per its Form 8-K filed June 4, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.4% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 32 asset managers below reported 12,531,170 for, 2,706,398 withheld, 24,479 abstained.

FORWITHHOLD
FOR: 12,531,170ABSTAIN: 24,479WITHHOLD: 2,706,398
Largest asset managers voting on “Election of Directors: Trevor Bezdek” at GoodRx Holdings, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,651,2540 00For
Columbia Threadneedle1,328,8230 00For
Dimensional00 01,188,530Withhold
Fidelity971,7980 00For
State Street1110 0859,899Withhold
Legg Mason734,7000 00For
Charles Schwab521,4560 00For
T. Rowe Price00 0187,094Withhold
Guardian Variable Products Trust176,7000 00For
WisdomTree00 0163,043Withhold
BlackRock103,5520 00For
Thrivent00 086,658Withhold
NORTHERN LIGHTS FUND TRUST III00 075,772Withhold
Northern Trust00 052,579Withhold
Russell Investments25,6220 00For
Jackson National00 21,2680Abstain
Victory Capital00 017,562Withhold
American Century00 015,585Withhold
Prudential/PGIM00 012,470Withhold
Blackstone Alternative Investment Funds00 012,200Withhold
Goldman Sachs00 011,738Withhold
Lincoln Financial00 08,959Withhold
New Age Alpha Funds Trust00 06,846Withhold
RBB FUND, INC.6,3790 00For
NORTHERN LIGHTS FUND TRUST II6,3740 00For

Showing the 25 largest of 32 asset managers. See all 32 in the interactive database.

4. 3. Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers

Outcome not verifiedFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Not verified

Combines 14 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 2,617,157,377AGAINST: 1,705,462
Details: description as filed, official tally, votes by 140 asset managers

Description as filed by funds: Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers.

GoodRx Holdings, Inc.’s own tally for this item (“3. Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers”): 2,617,157,377 for, 1,705,462 against, per its Form 8-K filed June 4, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 32 asset managers voting on “Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers.” at GoodRx Holdings, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,651,2540 00For
Columbia Threadneedle1,328,8230 00For
Dimensional1,188,5300 00For
Fidelity971,7980 00For
State Street859,856154 00For
Legg Mason734,7000 00For
Charles Schwab521,4560 00For
T. Rowe Price187,0940 00For
Guardian Variable Products Trust176,7000 00For
WisdomTree163,0430 00For
BlackRock103,5520 00For
Thrivent86,6580 00For
NORTHERN LIGHTS FUND TRUST III075,772 00Against
Northern Trust52,5790 00For
Russell Investments25,6220 00For
Jackson National21,2680 00For
Victory Capital17,5620 00For
American Century15,5850 00For
Prudential/PGIM12,4700 00For
Blackstone Alternative Investment Funds12,2000 00For
Goldman Sachs11,7380 00For
Lincoln Financial8,9590 00For
New Age Alpha Funds Trust6,8460 00For
RBB FUND, INC.6,3790 00For
NORTHERN LIGHTS FUND TRUST II6,3740 00For

Fund voting reports, all 32 managers: 15,180,684 for, 81,363 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 123 asset managers voting on “Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers.” at GoodRx Holdings, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Silver Lake Group, L.L.C.129,527,6080 00For
Francisco Partners Management, LP60,078,1840 00For
LAKEWOOD CAPITAL MANAGEMENT, LP4,885,7470 00For
Petrus Trust Company, LTA3,101,5380 00For
AMERIPRISE FINANCIAL INC2,402,8360 00For
Renaissance2,054,7910 00For
Rip Road Capital Partners LP1,923,0680 00For
Technology Crossover Management X, Ltd.1,653,5660 00For
Connor, Clark & Lunn Investment Management Ltd.1,380,7690 00For
BlackRock1,278,4850 00For
State Street1,231,591154 00For
GEODE CAPITAL MANAGEMENT, LLC1,056,4660 00For
Clearbridge Investments, LLC950,2540 00For
Two Sigma820,0150 00For
John Hancock727,0570 00For
Point72676,0020 00For
JACOBS LEVY EQUITY MANAGEMENT, INC617,3170 00For
STIFEL NICOLAUS & CO INC \MO\526,3170 00For
Charles Schwab521,4560 00For
TOCQUEVILLE ASSET MANAGEMENT L.P.330,0000 00For
Citadel298,0780 00For
ClariVest Asset Management LLC293,5300 00For
Northern Trust208,8200 00For
T. Rowe Price205,7140 00For
Vanguard144,3180 00For

Institutional-manager reports, all 123 managers: 218,336,138 for, 173,145 against, 80,000 abstained. Showing the 25 largest; see all in the interactive database.

5. 2. Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public…

Outcome not verifiedAUDIT-RELATEDReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 2,656,638,262AGAINST: 535,559
Details: description as filed, official tally, votes by 32 asset managers

Description as filed by funds: Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.

GoodRx Holdings, Inc.’s own tally for this item (“2. Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025”): 2,656,638,262 for, 535,559 against, per its Form 8-K filed June 4, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 32 asset managers below reported 15,185,904 for, 76,143 against.

FOR
FOR: 15,185,904AGAINST: 76,143
Largest asset managers voting on “Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public a” at GoodRx Holdings, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,651,2540 00For
Columbia Threadneedle1,328,8230 00For
Dimensional1,188,5300 00For
Fidelity971,7980 00For
State Street860,0100 00For
Legg Mason734,7000 00For
Charles Schwab521,4560 00For
T. Rowe Price187,0940 00For
Guardian Variable Products Trust176,7000 00For
WisdomTree163,0430 00For
BlackRock103,5520 00For
Thrivent86,6580 00For
NORTHERN LIGHTS FUND TRUST III075,772 00Against
Northern Trust52,5790 00For
Russell Investments25,6220 00For
Jackson National21,2680 00For
Victory Capital17,5620 00For
American Century15,5850 00For
Prudential/PGIM12,4700 00For
Blackstone Alternative Investment Funds12,2000 00For
Goldman Sachs11,7380 00For
Lincoln Financial8,9590 00For
New Age Alpha Funds Trust6,8460 00For
RBB FUND, INC.6,3790 00For
NORTHERN LIGHTS FUND TRUST II6,3740 00For

Showing the 25 largest of 32 asset managers. See all 32 in the interactive database.

Largest GoodRx Holdings, Inc. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 379,196,000 shares outstanding at the time of that meeting.

Fund voting reports: top GoodRx Holdings, Inc. shareholders by shares voted on “Approval, on an advisory (non-binding) basis, of the compensation of the Company's named…”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 2.28%
2Columbia Threadneedle 0.35%
3Dimensional 0.31%
4Fidelity 0.26%
5State Street 0.23%
6Legg Mason 0.19%
7Charles Schwab 0.14%
8T. Rowe Price 0.05%
9Guardian Variable Products Trust 0.05%
10WisdomTree 0.04%
Institutional-manager reports: top GoodRx Holdings, Inc. shareholders by shares voted on “Approval, on an advisory (non-binding) basis, of the compensation of the Company's named…”, 2024-2025
#Asset manager % of shares outstanding
1Silver Lake Group, L.L.C. 34.16%
2Francisco Partners Management, LP 15.84%
3LAKEWOOD CAPITAL MANAGEMENT, LP 1.29%
4Petrus Trust Company, LTA 0.82%
5AMERIPRISE FINANCIAL INC 0.63%
6Renaissance 0.54%
7Rip Road Capital Partners LP 0.51%
8Technology Crossover Management X, Ltd. 0.44%
9Connor, Clark & Lunn Investment Management Ltd. 0.36%
10BlackRock 0.34%

Reported GoodRx Holdings, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

GoodRx Holdings, Inc. holdings and ownership disclosed for the 2024-2025 proxy season
Holder % outstanding Disclosure
Francisco Partners GP IV, L.P. 15.84% 13D
Idea Men, LLC 11.38% 13D
Vanguard Group 2.27% 13F
Ameriprise Financial, Inc. 1.22% 13G
Renaissance Technologies 0.79% 13F
Dimensional Fund Advisors 0.60% 13F
BlackRock 0.47% 13F
State Street 0.47% 13F
Geode Capital 0.29% 13F
Citadel Advisors 0.29% 13F

Percentages above are of 379,196,000 shares outstanding, as reported by GoodRx Holdings, Inc. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from GoodRx Holdings, Inc.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At GoodRx Holdings, Inc.'s shareholder meeting held June 3, 2025, in the 2024-2025 proxy season, 140 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 577 separate fund positions. On the most widely held item on that ballot — Approval, on an advisory (non-binding) basis, of the compensation of the Company's named… — FOR was 99.9% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: GoodRx Holdings, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 4, 2025.

GoodRx Holdings, Inc. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.